GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Luxbright AB (OSTO:LXB) » Definitions » Debt-to-Equity

Luxbright AB (OSTO:LXB) Debt-to-Equity : 0.00 (As of Jun. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Luxbright AB Debt-to-Equity?

Luxbright AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was kr0.00 Mil. Luxbright AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was kr0.00 Mil. Luxbright AB's Total Stockholders Equity for the quarter that ended in Jun. 2023 was kr46.67 Mil. Luxbright AB's debt to equity for the quarter that ended in Jun. 2023 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Luxbright AB's Debt-to-Equity or its related term are showing as below:

OSTO:LXB' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02   Med: 0.09   Max: 0.36
Current: 0.01

During the past 5 years, the highest Debt-to-Equity Ratio of Luxbright AB was 0.36. The lowest was 0.02. And the median was 0.09.

OSTO:LXB's Debt-to-Equity is ranked better than
99.86% of 709 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs OSTO:LXB: 0.01

Luxbright AB Debt-to-Equity Historical Data

The historical data trend for Luxbright AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luxbright AB Debt-to-Equity Chart

Luxbright AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Equity
0.36 0.20 0.05 0.05 0.02

Luxbright AB Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.05 - 0.02 -

Competitive Comparison of Luxbright AB's Debt-to-Equity

For the Medical Devices subindustry, Luxbright AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Luxbright AB's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Luxbright AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Luxbright AB's Debt-to-Equity falls into.



Luxbright AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Luxbright AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Luxbright AB's Debt to Equity Ratio for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Luxbright AB  (OSTO:LXB) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Luxbright AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Luxbright AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Luxbright AB (OSTO:LXB) Business Description

Traded in Other Exchanges
Address
Arvid Wallgrens backe 20, Gothenburg, SWE, 41346
Luxbright AB is a technology company focusing on developing and commercializing a new generation of X-ray tubes. The company offers innovative X-ray tubes, generators, and future X-ray systems to international system suppliers in order to improve and protect lives by enabling higher resolution X-ray images. The X-ray tubes are a powerful, stable, and cost-effective alternative to conventional X-ray tubes.

Luxbright AB (OSTO:LXB) Headlines

No Headlines